Stockreport

Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 [Yahoo! Finance]

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors
PDF Krystal Biotech, Inc. (NASDAQ: KRYS ) is one of the top gene therapy stocks to buy according to hedge funds . On February 25, Guggenheim revised the price target on Kry [Read more]